Latin American experience with two low-dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel

Contraception

Volumn 62, Issue 3, 2000, Pages 131-135

  Bassol, S ^a,p   Alvarado, A ^b   Celis, C ^c   Cravioto, M C ^d   Peralta, O ^e   Montano R ^f   Novelli, J ^g   Albornoz, H ^h   Kesseru, E ^h   Soares, A ⁱ   Petracco, A ^j   Isaia, B ^k   Mendes, J ^l   Bahamondes, L ^m   De Melo, N R ⁿ   Reyes Marquez, R ^o   Albrecht, G ^o  

^a UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^c Hospital Luis Castelazo Ayala   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e Foot and Ankle Unit   (Chile)

^f HOSPITAL CARLOS VAN BUREN   (Chile)

^g HOSPITAL FRANCÉS   (Argentina)

^h Hospital De Clincias   (Argentina)

ⁱ Instituto de Dermatologia Prof Rubem David Azulay   (Brazil)

^j Centro Clinico Da Pontificia Universidad Catolica   (Brazil)

^k Clinica Privada   (Brazil)

^l Santa Casa de Misericordia de Sao Paulo   (Brazil)

^m Centro de Pesquisas Materno Infantis de Campinas   (Brazil)

ⁿ UNIVERSITY OF SÃO PAULO   (Brazil)

^o S A De C V Mexico   (Mexico)

^p Calle Gregorio A Garcia 198 Sur   (Mexico)

more..

Author keywords

Desogestrel; Dysmenorrhea; Ethinylestradiol; Gestodene; Intermenstrual bleeding

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTODENE; ORAL CONTRACEPTIVE AGENT;

ACNE; ADULT; ARGENTINA; ARTICLE; BRAZIL; BREAKTHROUGH BLEEDING; BREAST DISEASE; CHILE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSMENORRHEA; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MEXICO; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; ORAL CONTRACEPTION; SOUTH AND CENTRAL AMERICA; VERTIGO;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, HORMONAL; DESOGESTREL; DRUG COMBINATIONS; ETHINYL ESTRADIOL; FEMALE; HEADACHE; HUMANS; LATIN AMERICA; NORPREGNENES; PREGNANCY; WEIGHT GAIN;

EID: 0033635458     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(00)00153-0     Document Type: Article

References (10)

1. A comparison of the effects of 2 monophasic low-dose oral contraceptives on the inhibition of ovulation
2. Comparative profiles of reliability, cycle control and side effects of 2 oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinylestradiol
3. Extension of the pill-free period by 3 days in oral contraceptive users
4. German trial of an oral contraceptive containing 0.150 mg desogestrel plus 0.020 mg ethinylestradiol
5. EBelgian trial of an oral contraceptive containing 0
6. Evaluation of an oral contraceptive containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol in women aged 30 years or older
7. The effect of desogestrel, gestodene, and other factors on spotting and bleeding
8. A clinical comparison in Finland of 2 oral contraceptives containing 0.150 mg desogestrel in combination with 0.020 mg or 0.030 mg ethinylestradiol